Source: Annual Congress 2009 - Treatment of lung cancer
Disease area: Thoracic oncology

Abstract

INTRODUCTION: Combined chemotherapy and radiotherapy is an appropriate treatment for elderly NSCLC patients with good performance status (ECOG 0-1).
PATIENTS AND METHODS: We analyzed 25 lung cancer patients who were older then 65 years of age with locally advanced NSCLC diagnosed in Institute for Lung Disease of Vojvodina in Sremska Kamenica in 2000-2005. Patients received chemotherapy regimen with cisplatin 60mg/m2(day 1) and etoposide 100mg/m2 (day 1,2,3) in four weeks cycles combined with sequential radiotherapy (spleet-course 40Gy).
RESULTS: In these group of patient median survival were 16.28 months, median time to progression were 14.37 months. We acchived 1-year survival in 68% of patients (17 patients) and 2-year survival in 12% of patients(3 patients) , 3-year survival in 4% of patients(1 patients).
CONCLUSION: Advanced age alone should not preclude combined treatment for NSCLC. In fit elderly with advanced NSCLC combined chemotherapy and radiotherapy is tolerable treatment.

Rating:

Share or cite this content

Citations should be made in the following way:
D. Sazdanic-Velikic, N. Secen, D. Bursac, A. Tepavac, G. Popovic, B. Perin, M. Antonic (Sremska Kamenica, Republic Of Serbia). Survival of elderly patients with non-small lung cancer tretaed with combined chemotherapy and radiotherapy. Eur Respir J 2009; 34: Suppl. 53, 2648

Member's Comments

No comment yet.

Related content which might interest you: Combination of neoadjuvant and adjuvant chemotherapy in marginally resectable IIIA nonsmall cell lung cancer (NSCLC): long-term follow up Source: Eur Respir J 2006; 28: Suppl. 50, 772s Year: 2006 Locally advanced inoperable non-small cell lung cancer (NSCLC) treated by weekly paclitaxel/carboplatin chemotherapy with concomitant radiotherapy Source: Eur Respir J 2007; 30: Suppl. 51, 433s Year: 2007 Impact of neoadjuvant therapy on tumor resectability and survival of patients with locally advanced non-small cell lung cancer Source: Annual Congress 2011 - General thoracic surgery II Year: 2011 Comparison of quality of life in patients with non-small cell lung cancer treated by chemotherapy or radiotherapy Source: Eur Respir J 2004; 24: Suppl. 48, 75s Year: 2004 Survival and postoperative complication after neoadjuvant therapy in resectable stage IIIA-N2 non-small cell lung cancer: a balancing exercise Source: Eur Respir J 2003; 22: Suppl. 45, 31s Year: 2003 Second-line therapy in elderly patients with advanced nonsmall cell lung cancer Source: Eur Respir J 2014; 43: 240-249 Year: 2004 Long-term follow-up comparing postoperative chemotherapy or radiotherapy and surgery with surgery alone in resectable nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2001; 18: Suppl. 33, 131s Year: 2001 Treatment of potentially resectable locoregional (stage III) non-small cell lung cancer Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment Year: 2005 Role of chemotherapy in stage III non-small cell lung cancer (NSCLC): adjuvant or induction? Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer Year: 2006 Adjuvant and neoadjuvant therapy in nonsmall cell lung cancer (NSCLC) Source: Annual Congress 2006 - Clinical year in review Year: 2006 Non-small cell lung cancer - oral navelbine single-agent chemotherapy in elderly patient advanced stage or metastatic disease Source: Eur Respir J 2004; 24: Suppl. 48, 303s Year: 2004 Salvage surgery in patients with locally advanced non-small cell lung cancer – outcomes and longtime results Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 Chemotherapy with oral vinorelbine for geriatric patients with advanced non-small cell lung cancer – preliminary results Source: Eur Respir J 2006; 28: Suppl. 50, 752s Year: 2006 Correlation between parameters of quality of life in patients with non-small cell lung cancer treated by chemotherapy and radiotherapy Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology Year: 2007 The 7-year results of the surgical treatment of non-small cell lung cancer (NSCLC) patients and the influence of neoadjuvant treatment Source: Annual Congress 2007 - Therapy of thoracic malignancies Year: 2007 Neoadjuvant and adjuvant treatment for operable nonsmall cell lung cancer Source: Eur Respir Mon; 2009: 44: 244–259 Year: 2009 Chemotherapy with carboplatin and gemcitabine in patients with non resectable stages of non-small cell lung cancer (non-SCLC) Source: Eur Respir J 2007; 30: Suppl. 51, 436s Year: 2007 Is there any place for perioperative radiation therapy? Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts Year: 2005 Treatment of advanced non-small cell lung cancer Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment Year: 2005 Effectiveness of chemotherapy for advanced lung cancer in the elderly Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009